December 10, 2020
Takeda Pharmaceutical aims at sales of 5 trillion yen by FY2030 through contributions from future new drug candidates, CEO Christophe Weber said at the company’s pipeline briefing on December 9. The Japanese drug titan posted sales of around 3.3 trillion...read more